eClinical Tech News

CHO Plus has secured U.S. Patent No. 12,404,502 for a yeast cell–fusion platform designed to create hybrid strains with...

Virbac reported first-half 2025 results showing steady top-line expansion and softer profitability, while reaffirming full-year guidance and signaling a...

Virbac reported first-half 2025 revenue of €738.3 million, up 5.0% reported and 7.8% at constant exchange rates, with organic...

CorMedix has taken a $5 million strategic minority stake in Talphera, purchasing 9.09 million shares at $0.55 in a...

Nurexone Biologic has received a notice of allowance from the U.S. Patent and Trademark Office for a patent covering...

Immix Biopharma has secured a strategic investment from Goose Capital and Dr. Nancy T. Chang, the former Tanox CEO...

FOXO Technologies has signed a stock purchase agreement to acquire Vector BioSource, an information, data, and biospecimen sourcing provider...

Scancell released full-year results alongside a business update anchored by positive phase 2 melanoma data and a more straightforward...

Scancell has reported robust Phase 2 data for its next-generation DNA vaccine iSCIB1+ in advanced melanoma, confirmed plans to...

NanoNewron has secured a $2.5 million NIH STTR Phase 2 grant to advance NN-840, a blood–brain barrier–penetrant TNF-alpha inhibitor...